*The following content is generated by AI and is for reference only.
Overview
Tirzepatide is a dual GIP and GLP-1 receptor agonist developed for metabolic disorders. Its core synthesis involves complex peptide coupling and purification processes. The molecule features the chemical formula C259H402N68O78S with CAS No. 2362293-77-7.
Application
- Pharmaceutical manufacturing for Type 2 Diabetes management.
- Obesity treatment in clinical research settings.
- API production for weight loss formulation development.
Precautions
Strictly contraindicated in patients with personal or family history of medullary thyroid carcinoma. Storage requires controlled temperatures between 2°C and 8°C to maintain stability and potency.